|
1
|
Karaöz E, Demircan PC, Sağlam O, Aksoy A,
Kaymaz F and Duruksu G: Human dental pulp stem cells demonstrate
better neural and epithelial stem cell properties than bone
marrow-derived mesenchymal stem cells. Histochem Cell Biol.
136:455–473. 2011. View Article : Google Scholar
|
|
2
|
Gronthos S, Mankani M, Brahim J, Robey PG
and Shi S: Postnatal human dental pulp stem cells (DPSCs) in vitro
and in vivo. Proc Natl Acad Sci USA. 97:pp. 13625–13630. 2000;
View Article : Google Scholar :
|
|
3
|
Liu P, Cai J, Dong D, Chen Y, Liu X, Wang
Y and Zhou Y: Effects of SOX2 on proliferation, migration and
adhesion of human dental pulp stem cells. PLoS One.
10:e01413462015. View Article : Google Scholar :
|
|
4
|
Dieterich LC, Huang H, Massena S,
Golenhofen N, Phillipson M and Dimberg A: αB-crystallin/HspB5
regulates endothelial-leukocyte interactions by enhancing
NF-κB-induced up-regulation of adhesion molecules ICAM-1, VCAM-1
and E-selectin. Angiogenesis. 16:975–983. 2013. View Article : Google Scholar :
|
|
5
|
Grudzinska MK, Kurzejamska E, Bojakowski
K, Soin J, Lehmann MH, Reinecke H, Murry CE, Soderberg-Naucler C
and Religa P: Monocyte chemoattractant protein 1-mediated migration
of mesenchymal stem cells is a source of intimal hyperplasia.
Arterioscler Thromb Vasc Biol. 33:1271–9. 2013. View Article : Google Scholar
|
|
6
|
Luo Z, Li D, Kohli MR, Yu Q, Kim S and He
WX: Effect of Biodentine™ on the proliferation, migration and
adhesion of human dental pulp stem cells. J Dent. 42:490–497. 2014.
View Article : Google Scholar
|
|
7
|
Tate MC, Garcia AJ, Keselowsky BG, Schumm
MA, Archer DR and LaPlaca MC: Specific beta1 integrins mediate
adhesion, migration and differentiation of neural progenitors
derived from the embryonic striatum. Mol Cell Neurosci. 27:22–31.
2004. View Article : Google Scholar
|
|
8
|
Yang D, Sun S, Wang Z, Zhu P, Yang Z and
Zhang B: Stromal cell-derived factor-1 receptor
CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate
wound healing by migrating into skin injury areas. Cell Reprogram.
15:206–215. 2003.
|
|
9
|
Kanai F, Marignani PA, Sarbassova D, Yagi
R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC
and Yaffe MB: TAZ: A novel transcriptional co-activator regulated
by interactions with 14-3-3 and PDZ domain proteins. EMBO J.
19:6778–6791. 2000. View Article : Google Scholar :
|
|
10
|
Murakami M, Tominaga J, Makita R, Uchijima
Y, Kurihara Y, Nakagawa O, Asano T and Kurihara H: Transcriptional
activity of Pax3 is co-activated by TAZ. Biochem Biophys Res
Commun. 339:533–539. 2006. View Article : Google Scholar
|
|
11
|
Hong JH, Hwang ES, McManus MT, Amsterdam
A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp
PA, et al: TAZ, a transcriptional modulator of mesenchymal stem
cell differentiation. Science. 309:1074–1078. 2005. View Article : Google Scholar
|
|
12
|
Murakami M, Nakagawa M, Olson EN and
Nakagawa O: A WW domain protein TAZ is a critical coactivator for
TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc
Natl Acad Sci USA. 102:pp. 18034–18039. 2005; View Article : Google Scholar :
|
|
13
|
Park KS, Whitsett JA, Di Palma T, Hong JH,
Yaffe MB and Zannini M: TAZ interacts with TTF-1 and regulates
expression of surfactant protein-C. J Biol Chem. 279:17384–17390.
2004. View Article : Google Scholar
|
|
14
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar :
|
|
15
|
Hong JH and Yaffe MB: TAZ: A
beta-catenin-like molecule that regulates mesenchymal stem cell
differentiation. Cell Cycle. 5:176–179. 2006. View Article : Google Scholar
|
|
16
|
Jeong H, Bae S, An SY, Byun MR, Hwang JH,
Yaffe MB, Hong JH and Hwang ES: TAZ as a novel enhancer of
MyoD-mediated myogenic differentiation. FASEB J. 24:3310–3320.
2010. View Article : Google Scholar
|
|
17
|
Suh JS, Kim KS, Lee JY, Choi YJ, Chung CP
and Park YJ: A cell-permeable fusion protein for the mineralization
of human dental pulp stem cells. J Dent Res. 91:90–96. 2012.
View Article : Google Scholar
|
|
18
|
Xue P, Wu X, Zhou L, Ma H, Wang Y, Liu Y,
Ma J and Li Y: IGF1 promotes osteogenic differentiation of
mesenchymal stem cells derived from rat bone marrow by increasing
TAZ expression. Biochem Biophys Res Commun. 433:226–231. 2013.
View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Lai D, Ho KC, Hao Y and Yang X: Taxol
resistance in breast cancer cells is mediated by the hippo pathway
component TAZ and its downstream transcriptional targets Cyr61 and
CTGF. Cancer Res. 71:2728–2738. 2011. View Article : Google Scholar
|
|
21
|
Iohara K, Zheng L, Wake H, Ito M, Nabekura
J, Wakita H, Nakamura H, Into T, Matsushita K and Nakashima M: A
novel stem cell source for vasculogenesis in ischemia: Subfraction
of side population cells from dental pulp. Stem Cells.
26:N2408–N2418. 2008. View Article : Google Scholar
|
|
22
|
Nakamura S, Yamada Y, Katagiri W, Sugito
T, Ito K and Ueda M: Stem cell proliferation pathways comparison
between human exfoliated deciduous teeth and dental pulp stem cells
by gene expression profile from promising dental pulp. J Endod.
35:1536–1542. 2009. View Article : Google Scholar
|
|
23
|
Hong W and Guan KL: The YAP and TAZ
transcription co-activators: Key downstream effectors of the
mammalian Hippo pathway. Semin Cell Dev Biol. 23:785–793. 2012.
View Article : Google Scholar :
|
|
24
|
Wang K, Degerny C, Xu M and Yang XJ: YAP,
TAZ and Yorkie: A conserved family of signal-responsive
transcriptional coregulators in animal development and human
disease. Biochem Cell Biol. 87:77–91. 2009. View Article : Google Scholar
|
|
25
|
Zeng Q and Hong W: The emerging role of
the hippo pathway in cell contact inhibition, organ size control,
and cancer development in mammals. Cancer Cell. 13:188–192. 2008.
View Article : Google Scholar
|
|
26
|
Chan SW, Lim CJ, Guo K, Ng CP, Lee I,
Hunziker W, Zeng Q and Hong W: A role for TAZ in migration,
invasion, and tumorigenesis of breast cancer cells. Cancer Res.
68:2592–2598. 2008. View Article : Google Scholar
|
|
27
|
Lei QY, Zhang H, Zhao B, Zha ZY, Bai F,
Pei XH, Zhao S, Xiong Y and Guan KL: TAZ promotes cell
proliferation and epithelial-mesenchymal transition and is
inhibited by the hippo pathway. Mol Cell Biol. 28:2426–2436. 2008.
View Article : Google Scholar :
|
|
28
|
Wang Q, Xu Z, An Q, Jiang D, Wang L, Liang
B and Li Z: TAZ promotes epithelial to mesenchymal transition via
the upregulation of connective tissue growth factor expression in
neuroblastoma cells. Mol Med Rep. 11:982–988. 2015.
|
|
29
|
Dhar A and Ray A: The CCN family proteins
in carcinogenesis. Exp Oncol. 32:2–9. 2010.
|
|
30
|
Leask A and Abraham DJ: All in the CCN
family: Essential matricellular signaling modulators emerge from
the bunker. J Cell Sci. 119:4803–4810. 2006. View Article : Google Scholar
|
|
31
|
Leivonen SK and Kähäri VM: Transforming
growth factor-beta signaling in cancer invasion and metastasis. Int
J Cancer. 121:2119–2124. 2007. View Article : Google Scholar
|
|
32
|
Kim KM, Choi YJ, Hwang JH, Kim AR, Cho HJ,
Hwang ES, Park JY, Lee SH and Hong JH: Shear stress induced by an
interstitial level of slow flow increases the osteogenic
differentiation of mesenchymal stem cells through TAZ activation.
PLoS One. 9:e924272014. View Article : Google Scholar :
|
|
33
|
Labbé E, Lock L, Letamendia A, Gorska AE,
Gryfe R, Gallinger S, Moses HL and Attisano L: Transcriptional
cooperation between the transforming growth factor-beta and Wnt
pathways in mammary and intestinal tumorigenesis. Cancer Res.
67:75–84. 2007. View Article : Google Scholar
|
|
34
|
Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, Du
ZP, Lv Z, Gu W, Pan F, Xu XE, et al: Involvement of CYR61 and CTGF
in the fascin-mediated proliferation and invasiveness of esophageal
squamouscell cell carcinomas cells. Am J Pathol. 76:939–951. 2010.
View Article : Google Scholar
|
